In Committee from the Senate of Canada - Social Affairs, Science and Technology - March 7, 2013
Social Affairs, Science and Technology
Senators continue their discussions on off-label use of prescription pharmaceuticals. Off-label refers to the practice of prescribing medication for a use not approved of by a regulatory body.
Dr. Brian O'Rourke from the Canadian Agency for Drugs and Technologies in Health, Dr. Paula Rochon of the Institute for Clinical Evaluative Sciences and Dr. Stuart MacLeod with the Child and Family Research Institute (as an individual) outline some of the concerns and benefits of the common practice.